BALCHEM CORPORATION Key Metrics

17 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

M-Score (Beneish; >-1.78 flags risk)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

EPS (Diluted)↑+61.5% +$2
$5
Book Value Per Share↑+43.7% +$12
$39
Free Cash Flow Per Share↑+74.5% +$3
$7
Cash Per Share↓-27.6% -$1
$2
Revenue Per Share↑+30.1% +$7
$32
OCF Per Share↑+35.2% +$2
$7
Return on Equity↑+1.6pts
12.9%
Return on Assets↑+1.4pts
9.5%
Return on Invested Capital↑+2.1pts
13.5%
Debt to Equity↓-70.3% -$1
0.23
Current Ratio↓-7.5% -$0
2.07
Quick Ratio↓-17.4% -$0
1.33
Asset Turnover↓-5.9% -$0
0.64
Days Sales Outstanding↓-5.8% -$3
50.53
Days Inventory On Hand↑+20.4% +$12
71.98
R&D / Revenue↑+0.1pts
1.8%
SBC / Revenue↑+0.4pts
1.7%
Capex / Revenue↑+2.2pts
5.2%
Working Capital↑+6.1% +$11M
$189M
Net Current Asset Value↓-80957.7% -$63M
$-63M
Invested Capital↑+43.4% +$380M
$1.26B
OCF / Net Income↓-16.3% -$0
1.40
FCF / Net Income↑+8.1% +$0
1.40
Accruals Ratio (Sloan)↑+1.7pts
-3.7%
Net Debt↑+27.8% +$29M
$-75M
Net Debt / EBITDA↑+50.0% +$0
-0.29
Interest Coverage
-20.48
Cash Coverage
-21.19
Dividend Coverage↓-10.7% -$1
7.66
Capex Coverage↓-54.4% -$3
2.82
Tangible Common Equity↑+19.2% +$50M
$308M
TCE / Total Assets↓-3.3pts
18.3%
Goodwill / Total Assets↑+4.7pts
48.4%
NOPAT↑+66.4% +$65M
$163M
Cash ROIC↑+3.4pts
18.0%
WC / Revenue↓-4.1pts
18.2%
Capex / D&A↑+120.6% +$1
0.95
Reinvestment Rate↓-11.7pts
-21.7%
Total Payout Ratio↑+31.6pts
87.8%
Asset Growth vs Revenue Growth↑+9.0pts
-1.7%
Revenue 5Y CAGR↑+0.4pts
8.1%
EPS 5Y CAGR↑+1.4pts
12.8%
FCF 5Y CAGR↑+4.8pts
12.8%
EBITDA 5Y CAGR↑+4.3pts
9.4%
Book Value 5Y CAGR↓-2.3pts
8.7%
Stock Price (FY-end)↓-7.0% -$11
$153
Market Cap↓-7.2% -$385M
$5.00B
P/E Ratio↓-42.4% -$24
32.29
P/S Ratio↓-28.5% -$2
4.82
P/B Ratio↓-35.2% -$2
3.98
P/TB Ratio↓-22.1% -$5
16.23
P/OCF Ratio↓-31.2% -$10
23.09
P/FCF Ratio↓-46.7% -$20
23.09
FCF Yield↑+2.0pts
4.3%
Dividend Yield↑+0.2pts
0.6%
Shareholder Yield↑+1.6pts
2.4%
Graham Number↑+52.3% +$22
$64
Shares Variation (YoY)↓-0.9pts
-0.3%
Beta (5Y)↓-8.6% -$0
0.77
Cost of Equity↓-0.4pts
8.4%
Cost of Debt (after tax)
2.2%
WACC↓-0.4pts
8.4%
ROIC - WACC Spread↑+2.4pts
5.2%
52W High↑+4.2% +$7
$175
52W Low↑+33.8% +$35
$139
Trailing Return 1M↓-8.5pts
-0.9%
Trailing Return 6M↓-34.4pts
-5.5%
Trailing Return 1Y↓-53.5pts
-6.6%
Trailing Return 5Y↓-68.4pts
39.9%
F-Score (Piotroski)↑+60.0% +$3
8.00
M-Score (Beneish)
-2.91
Z-Score (Altman)↓-24.8% -$3
9.09

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual